Dihydrotestosterone
Jump to navigation
Jump to search
| Dihydrotestosterone | |
|---|---|
| Term | Dihydrotestosterone |
| Short definition | Dihydrofolate reductase inhibitors - (pronounced) (dy-HY-droh-FOH-layt ree-DUK-tays in-HIH-bih-ter) A substance that can accumulate in cancer cells and prevent them from using folic acid. Folate is a nutrient that rapidly dividing cells need to make DNA. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Dihydrotestosterone - (pronounced) (dy-HY-threatening-tes-TOS-teh-rone) hormone made from testosterone in the prostate, testicles, and certain other tissues. It is needed to develop and maintain male sex characteristics such as facial hair, deep voice and muscle growth. High levels of dihydrotestosterone can promote prostate cancer growth and make treatment more difficult. Also called androstanolone and DHT
External links
- Medical encyclopedia article on Dihydrotestosterone
- Wikipedia's article - Dihydrotestosterone
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski